Back
Kaival Brands Innovations Group Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
19
KAVL
Kaival Brands Innovations Group
Last Price:
$0.57
Seasonality Move:
668.09%
Buy
61
ALNY
Alnylam Pharmaceuticals
Last Price:
$283.34
Seasonality Move:
3.3%
Sell
19
Kaival Brands Innovations Group (KAVL)
is a Sell
Is Kaival Brands Innovations Group a Buy, Sell or Hold?
-
The current Kaival Brands Innovations Group [KAVL] share price is $0.57. The Score for KAVL is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
KAVL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
61
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $283.34. The Score for ALNY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KAVL Stock Price Chart
What is Kaival Brands Innovations Group's stock price today?
-
The Kaival Brands Innovations Group share price today is $0.57Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KAVL is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $283.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
KAVL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.12 | Sell |
Relative Strength Index (14 RSI): | 28.89 | Sell |
Chaikin Money Flow: | 79059 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.62 - 0.9) | Sell |
Bollinger Bands (100): | (0.71 - 1.15) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.81 | Buy |
Relative Strength Index (14 RSI): | 68.89 | Buy |
Chaikin Money Flow: | 1798941 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (239.98 - 259.48) | Buy |
Bollinger Bands (100): | (240.26 - 271.94) | Buy |
KAVL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.6 | Sell |
20-day SMA: | 0.7 | Sell |
50-day SMA: | 1 | Sell |
200-day SMA: | 1.04 | Sell |
8-day EMA: | 0.61 | Sell |
20-day EMA: | 0.72 | Sell |
50-day EMA: | 0.87 | Sell |
200-day EMA: | 1.61 | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 251.71 | Buy |
20-day SMA: | 247.77 | Buy |
50-day SMA: | 256.39 | Buy |
200-day SMA: | 250.79 | Buy |
8-day EMA: | 256.23 | Buy |
20-day EMA: | 252.43 | Buy |
50-day EMA: | 253.95 | Buy |
200-day EMA: | 242.96 | Buy |
Kaival Brands Innovations Group Earnings Growth & KAVL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $0.95 per share, and an increase next year of $2.74 per share.
Kaival Brands Innovations Group Technical Analysis
Mar 10 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
10 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |